No Data
No Data
OraSure Technologies Stock Plan Expansion and Director Elections
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA), Amgen (AMGN) and Orasure Technologies (OSUR)
Pinning Down OraSure Technologies, Inc.'s (NASDAQ:OSUR) P/E Is Difficult Right Now
With a median price-to-earnings (or "P/E") ratio of close to 17x in the United States, you could be forgiven for feeling indifferent about OraSure Technologies, Inc.'s (NASDAQ:OSUR) P/E ratio of 15.7
OraSure Is Maintained at Neutral by JP Morgan
OraSure Is Maintained at Neutral by JP Morgan
JPMorgan Adjusts OraSure Technologies Price Target to $6 From $7, Maintains Neutral Rating
OraSure Technologies (OSUR) has an average rating of Hold and price targets ranging from $5.50 to $9, according to analysts polled by Capital IQ. Price: 5.13, Change: +0.27, Percent Change: +5.56
JP Morgan Maintains Neutral on OraSure Technologies, Lowers Price Target to $6
JP Morgan analyst Casey Woodring maintains OraSure Technologies (NASDAQ:OSUR) with a Neutral and lowers the price target from $7 to $6.